OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
OrthoPediatrics (Nasdaq: KIDS), a company specializing in pediatric orthopedics, has announced it will release its first quarter 2025 financial results on May 7, 2025, after market close. The company will host a conference call the same day at 4:30 p.m. ET to discuss the results.
Investors can access both the live and archived webcast of the earnings call through the Events & Presentations section of the company's website at www.orthopediatrics.com. The webcast recording will remain available for at least 90 days following the event.
OrthoPediatrics (Nasdaq: KIDS), un'azienda specializzata in ortopedia pediatrica, ha annunciato che pubblicherà i risultati finanziari del primo trimestre 2025 il 7 maggio 2025, dopo la chiusura dei mercati. Lo stesso giorno, alle 16:30 ET, la società terrà una conference call per discutere i risultati.
Gli investitori potranno seguire la diretta e rivedere la registrazione della conference call nella sezione Eventi e Presentazioni del sito web aziendale www.orthopediatrics.com. La registrazione resterà disponibile per almeno 90 giorni dopo l'evento.
OrthoPediatrics (Nasdaq: KIDS), una empresa especializada en ortopedia pediátrica, ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 el 7 de mayo de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica ese mismo día a las 4:30 p.m. ET para comentar los resultados.
Los inversores podrán acceder a la transmisión en vivo y a la grabación de la llamada de resultados a través de la sección Eventos y Presentaciones en la página web de la empresa www.orthopediatrics.com. La grabación estará disponible por al menos 90 días después del evento.
OrthoPediatrics (나스닥: KIDS)는 소아 정형외과 전문 회사로, 2025년 1분기 재무 실적을 2025년 5월 7일 장 마감 후 발표할 예정이라고 밝혔습니다. 회사는 같은 날 오후 4시 30분(동부시간)에 실적에 대해 논의하는 컨퍼런스 콜을 개최합니다.
투자자들은 회사 웹사이트 www.orthopediatrics.com의 이벤트 및 프레젠테이션 섹션을 통해 실적 발표 컨퍼런스 콜의 생중계 및 녹화 영상을 시청할 수 있습니다. 녹화 영상은 행사 후 최소 90일간 제공됩니다.
OrthoPediatrics (Nasdaq : KIDS), une entreprise spécialisée en orthopédie pédiatrique, a annoncé qu'elle publiera ses résultats financiers du premier trimestre 2025 le 7 mai 2025, après la clôture des marchés. La société tiendra une conférence téléphonique le même jour à 16h30 ET pour discuter des résultats.
Les investisseurs pourront accéder à la diffusion en direct ainsi qu'à l'enregistrement de la conférence téléphonique via la section Événements et Présentations du site internet de l'entreprise, www.orthopediatrics.com. L'enregistrement restera disponible pendant au moins 90 jours après l'événement.
OrthoPediatrics (Nasdaq: KIDS), ein auf pädiatrische Orthopädie spezialisiertes Unternehmen, hat angekündigt, seine Finanzergebnisse für das erste Quartal 2025 am 7. Mai 2025 nach Börsenschluss zu veröffentlichen. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren können sowohl den Live-Stream als auch die Aufzeichnung des Gewinnaufrufs über den Bereich Events & Präsentationen auf der Unternehmenswebsite www.orthopediatrics.com abrufen. Die Aufzeichnung wird mindestens 90 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
When will OrthoPediatrics (KIDS) release Q1 2025 earnings?
How can investors access OrthoPediatrics (KIDS) Q1 2025 earnings call?
What time is OrthoPediatrics (KIDS) Q1 2025 earnings call?
How long will OrthoPediatrics (KIDS) Q1 2025 earnings call replay be available?
